La catena delle opzioni mostra i dati chiave delle opzioni azionarie di MiNK Therapeutics a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per MiNK Therapeutics..

MiNK Therapeutics (NASDAQ:INKT) Azioni, Catena delle Opzioni

MINK THERAPEUTICS INC

MiNK Therapeutics

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

MiNK Therapeutics Inc

Press Releases

MiNK Therapeutics to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report

Earnings

MiNK Therapeutics Reports Fourth Quarter & Full Year 2024 Results and Highlights Business Progress

MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report

MiNK Therapeutics Reports Q1 2025 Results and Highlights Clinical & Strategic Progress

News

Financing

General

MiNK Therapeutics Awarded Prestigious NIAID Grant to Advance Allo-iNKT Cell Therapy for Prevention of GvHD in Stem Cell Transplant Patients

MiNK Therapeutics Announces Virtual Annual Shareholders Meeting

Health Care

MiNK Therapeutics Announces Publication of Complete Remission Following Allogeneic iNKT Cell Therapy in Metastatic Testicular Cancer

MiNK Therapeutics Announces Frontiers in Immunology Publication Highlighting iNKT Cells as a Dual-Function Platform Key to Overcoming Barriers in Solid Tumor Cell Therapy

MiNK Therapeutics Reports Clinical and Strategic Milestones and Second Quarter 2025 Results

INKT

ABVC BioPharma

Aligos Therapeutics

Adlai Nortye Ltd. - American Depositary Shares

Adlai Nortye

Applied Therapeutics, Inc. - Common Stock

Applied Therapeutics

Artiva Biotherapeutics, Inc. - Common Stock

Artiva Biotherapeutics

Alterity Therapeutics Limited - American Depositary Shares

Alterity Therapeutics

BeyondSpring

Cibus

Coeptis Therapeutics Holdings, Inc. - Common Stock

Coeptis Therapeutics

CEL-SCI

Fortress Biotech

Gain Therapeutics

Genenta Science S.p.A. - American Depositary Shares

Genenta Science

Insight Molecular Diagnostics Inc. - Common Stock

Insight Molecular

Immix Biopharma

INmune Bio

Opus Genetics

Invivyd

Liminatus Pharma, Inc. - Class A Common Stock

Liminatus Pharma

Metagenomi

MediciNova

Ovid Therapeutics

Repare Therapeutics

Sutro Biopharma

Unicycive Therapeutics, Inc. - Common Stock

Unicycive Therapeutics

HC Wainwright & Co.

Baird

Evercore ISI Group

Comments

MiNK Therapeutics

MiNK Therapeutics (INKT) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO